-

Huntington Hospital – Notice of Unauthorized Access to Personal Information

HUNTINGTON, N.Y.--(BUSINESS WIRE)--Huntington Hospital has sent notices to approximately 13,000 patients about an incident involving the unauthorized access of personal information. The hospital learned that a night shift employee improperly accessed electronic medical patient records in violation of its policies. After a thorough investigation, on February 25, 2019, the hospital determined that the employee improperly accessed patient information without role-based authorization between October 2018 and February 2019. The employee was immediately suspended, and he was subsequently terminated. In addition, Huntington Hospital notified law enforcement of the incident. The hospital cooperated with the law enforcement investigation, which included following instructions to delay notifying any patients who were potentially impacted by this incident through November 2021. The law enforcement investigation resulted in the former employee being charged with a criminal HIPAA violation.

There is no evidence that the former employee accessed Social Security numbers, insurance information, credit card numbers or other payment-related information. The patient information accessed by the former employee may have included demographic-type information such as name, date of birth, telephone number, address, internal account number and medical record number; and clinical information such as diagnoses, medications, laboratory results, course of treatment, the names of health care providers, and/or other treatment-related information.

Huntington Hospital has a robust compliance program that includes ongoing training of its employees, implementation of security tools to monitor access to medical record applications, and audits of medical record access. The hospital has taken additional steps to prevent this type of incident from occurring in the future, including bolstering access controls and targeted re-training of staff on the importance of protecting patient confidentiality.

As an added precaution, Huntington Hospital is offering all impacted patients complimentary identity theft protection services through Experian IdentityWorksSM for one (1) year, unless a longer time period was required by applicable state law.

This notice is being provided in accordance with the media notice requirements of the Health Insurance Portability and Accountability Act, as amended by Health Information Technology for Economic and Clinical Health Act. Huntington Hospital has notified impacted patients and will notify relevant regulatory bodies, including the U.S. Department of Health and Human Services.

Contacts

Barbara Osborn
516-321-6702
bosborn@northwell.edu

Huntington Hospital


Release Versions

Contacts

Barbara Osborn
516-321-6702
bosborn@northwell.edu

More News From Huntington Hospital

Feinstein Institutes Research Reveals Link Between Five Senses and Immune System

MANHASSET, N.Y.--(BUSINESS WIRE)--New research from Northwell Health’s Feinstein Institutes for Medical Research suggests the relationship between the five senses and immune system plays a larger role in protecting humans from disease than previously thought. The research, published recently by Trends in Immunology and led by Douglas F. Nixon, MD, PhD, director of the Feinstein Institutes’ Institute of Translational Research, shows the five senses – sight, smell, taste, touch and sound – do mor...

Feinstein Institutes 2025 Ross Prize awarded to Scripps Research’s Dr. Jeffery W. Kelly

MANHASSET, N.Y.--(BUSINESS WIRE)--The Feinstein Institutes for Medical Research has selected Jeffery W. Kelly, PhD, from Scripps Research, to receive the 12th annual Ross Prize in Molecular Medicine. Dr. Kelly is recognized for his groundbreaking research into protein folding, misfolding and aggregation, along with their impact on developing novel therapeutic strategies for amyloid diseases. The prize will be presented on June 4, in conjunction with the New York Academy of Sciences (NYAS), at T...

Feinstein Institutes Research Finds New Vagus Nerve Stimulation Method Targets Specific Fibers, Shows Promise for Improving Therapeutic Efficacy

MANHASSET, N.Y.--(BUSINESS WIRE)--Researchers at the Feinstein Institutes for Medical Research have developed a groundbreaking new method for vagus nerve stimulation (VNS) that offers unprecedented control over nerve fiber activation, paving the way for more effective and personalized treatments for a wide range of chronic diseases. The study, led by Stavros Zanos, MD, PhD, associate professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes, and published this week in Nat...
Back to Newsroom